BP8 Sources Bird’s Nest Products from Chinese State-Owned Conglomerate China National Pharmaceutical Group Corporation (Commonly Known as Sinopharm)
The Board ofBPH Global Ltd (ASX: BP8) (Company) is pleased to announce that its wholly- owned, China-based subsidiary Foshan Gedishi Biotechnology Co








